Overview

• Healthcare professionals and researchers involved in MS clinical care or research.
• Neurologists.
• Clinical researchers.
• Residents with interest in Neurology.

• Pre-congress on December 3, 2026.
• Plenary sessions covering all major topics in MS.
• Full-day parallel session in collaboration with the IOMSNMSC aimed at MENA region nurses.
• European Charcot Foundation Symposium.

• MS Diagnosis.
• Biomarkers in MS.
• MS Treatment.
• Update on Progressive MS.
• Oral Presentations.
• Updates in MS.
• The Role of Patient Reported Outcomes.
• NMOSD and MOGAD.
• Hot Topics in MS.

Pre-congress activities include MENACTRIMS pre-congress activities, neuroimaging and neuroradiology parallel courses, along with educational foundation and industry-driven pre-congress sessions taking place in parallel.

Pre-congress registrations have a separate form.

• Learn about the latest advancements in Multiple Sclerosis (MS) research, including innovative therapies and new treatment approaches.
• Discover the role of biomarkers and precision medicine in personalizing MS treatment strategies.
• Understand the impact of genetics and environmental factors in MS pathogenesis and risk assessment.
• Explore cutting-edge disease-modifying therapies (DMTs) and their role in slowing disease progression.
• Gain insights into advanced imaging techniques, including high-resolution MRI, for better MS diagnosis and monitoring.
• Learn about the latest guidelines and updates in MS management, including best practices for relapse treatment and symptom control.
• Explore advancements in neurorehabilitation, lifestyle interventions, and mental health management for MS patients.
• Stay updated on novel treatment targets and immunotherapy advancements in MS.
• Discuss challenges in MS patient care, disability management, and healthcare policies to enhance quality of life.

The Eleventh MENACTRIMS Congress is accredited for 15.0 CME Hours (category 1) by Dubai Health.